CROI 2018 Abstract eBook

Abstract eBook

Keyword Index

KEYWORD INDEX

(1 → 3)-β-d-Glucan 254 10-1074 1062 18F-FDG-PT/CT 988 3BNC117 1062 3D speckle-tracking 698 Abacavir 673, 674, 677LB, 80 ABCG2 rs2231142 467 Abciximab 251LB

Antibody effector functions 300 Antibody engineering 296LB Antibody glycosylation 297, 300, 312 Antibody response 227, 301 Antibody-dependent cell-mediated cytotoxicity 298 Antifungal 792 Antigen presentation 206 Antigen processing and presentation 331 Antigen-specific responses 234 Antigen/antibody assays 227 Antiretroviral treatment 138, 670, 758, 862, 1093 Antiretroviral therapy (ART) 1046, 1076, 1079, 1081, 1082, 1088, 1092, 1095, 1097, 1099, 1104, 1107, 1108, 1118, 112, 1126, 1155, 116, 136, 139, 173, 196, 210, 211, 229, 234, 235, 238, 24, 251LB, 262, 263, 266, 269, 289, 290, 30LB, 31, 317, 334, 341, 343, 345, 349, 362, 376, 392, 403LB, 414, 425, 428, 429, 437, 459, 46, 461, 466, 471, 475, 478, 486, 487, 488, 495, 496, 503, 510, 511, 512, 513, 526, 527, 528, 538, 540, 550, 551, 553, 573, 647, 657, 67, 671, 672, 673, 679, 683, 69LB, 702, 712, 722, 735, 737, 74, 741, 752, 754, 761, 763, 791, 795, 803, 804, 810, 812, 813, 815, 829, 830, 831, 832, 839, 852, 854, 858, 861, 864, 866, 868, 876, 879, 887, 893, 896, 899, 910, 912, 93, 941, 95, 97, 985 Antisense protein ASP 171 Antiviral activity 302 Apnea-hypopnea index 697

Best practice alert 576 Bictegravir 22, 500, 506, 532, 546, 618, 844 Biodegradable 486 Biomarker 157, 218, 391, 434, 451, 453, 639, 729, 765 Birth cohort 576 Birth outcomes 830, 833 Blastocystis 802 Blinding cataracts 797 Blips 69LB Block and lock 328 Blood donation 905, 1002, 1003 Blood safety 1002, 1003 Blood-brain barrier 444 Body composition 733 Body mass index 734, 802 Bone 719, 720, 721, 722, 723, 724, 725, 726, 727, 843, 872 Bone turnover markers 719 Botswana 136, 340, 542, 552, 615, 616, 881, 936, 950, 1156 Brain 124, 435, 452, 472, 474 Brain structure 121, 433 Breast-milk transmission 317, 827 Broadly neutralizing antibodies 15, 192, 290, 291, 292, 294, 295, 296LB, 312, 82 C-Peptide 742 Cabergoline 811 Cabotegravir 458, 485 Cancer 132, 134, 649, 650, 651, 652, 653, 656LB, 667, 764 CAR T cells 351 Cardio-ankle vascular index 856 Cardiometabolic health 686 Cardiovascular disease risk 412, 631, 673, 675, 676, 677LB, 678, 679, 681, 682, 683, 685, 686, 687, 691, 693, 694, 695, 696, 697, 699, 700, 705, 706, 709, 710, 713, 716, 75, 76, 765, 80 Care continuum 91, 578, 820, 886, 902, 913, 939, 974, 1044, 1086, 1098, 1100, 1109, 1125, 1128, 1137, 1149 Care retention 1094 Care-delivery model 820, 892, 1125 Caregiver 852 Carotid artery 78 Carotid intima-media thickness 78, 671, 688 Carotid plaque 78, 708 cART 421, 507 Cascade of care 94, 595, 596, 598, 889, 892, 900, 1007, 1083, 1096 Case control 554, 764 Case management 1125 Cause-specific mortality 490, 886, 974, 1133 CCR5 322, 351, 481 CCR6 T cells 240 CD11b 213 CD32 155, 157, 158, 385, 387, 389, 390 CD32a 156, 367, 388, 396 CD39 749 CD4 16LB, 369 • Binding site 296LB • Cell depletion 215, 350 • Central memory 20 • T cell 209, 278, 310, 320, 322, 325, 383, 423, 472, 652, 802, 887, 1121 • CD4/CD8 cell ratio 448, 707, 745 CD73 749 CD8 T cells 67, 118, 186, 222, 241, 242, 276, 277, 278, 279, 280, 355, 863

Acceptability 944, 1017, 1064 Access to care 826, 991, 1006 Activation 158, 363, 385 Active tracing 31 Acute hepatitis C 128, 129, 585, 590

Acute HIV infection 1000, 1120, 1137, 1158, 122, 208, 233LB, 260, 262, 285, 339, 430, 437, 445, 448, 573, 66, 699, 998, 999

Addiction 1158 Adenosine 749

Adherence 1027, 1034, 1043, 1102, 1115, 1131, 1135, 140, 144LB, 25, 46, 460, 462, 512, 513, 514, 515, 530, 812, 813, 814, 815 Adiponectin 706 Adipose tissue 686, 686, 736, 737 Adjuvant 305 Administrative data 894 Adolescents 702, 843, 844, 847, 849, 918, 923, 926, 984, 1057, 1065, 1067, 1135, 1146 Africa 1049, 1051, 1084, 1085, 1099, 1114, 1117LB, 1124, 114, 602, 649, 655, 731, 748, 770, 802, 873, 875, 884, 887, 90, 902, 912 Ag/Ab Combo 567 Aging 438, 757, 759, 890, 891, 909 Advanced HIV-disease 493, 495, 887, 898, 1084 Adverse events 139, 39LB, 401, 402, 494, 832 AIDSVAX B/E 306 Alcohol 605, 1144 Algorithm 569 Alpha 4 beta 7 205 Alpha-1 antitrypsin 751 American Indians/Alaska Natives 930 Amphotericin 35, 792 Amyloid 438 Anal cancer 663, 664, 665, 666, 1116 Anal HPV 662, 663, 664, 1116 Anal HSIL 664, 666, 1116 Anal swabs 1116 Analytic treatment interruption 231, 334, 445 Anaplastic large cell lymphoma 667 Anatomic compartments 362 ANG-2 414 Angiotensin receptor blockers 314 Animal model 450, 562, 674, 73LB, 85 Ankle brachial index 707 Antacids 470 Antenatal 935 Anti-ASP antibodies 171 Anti-HIV 289 Antibiotics 256 Antibodies 1004, 288, 289, 297, 298, 315, 392, 73LB AIDS diagnosis rates 889 AIDS events 169, 517, 793 AIDS Indicator survey 824 AIDS-free survival 138, 853 AIDS-related malignancy 656LB

APOBEC3 182LB, 199, 375 APOBEC3G 114, 151, 194 APOBEC3H 114 APOL1 731 Apolipoprotein(a) size polymorphism 672 Apoptosis 224LB Appointment scheduling 1082

Areal Interpolation 1154 Arterial inflammation 685 Arterial stiffness 679, 716, 856, 857 Asia 404 Asian 718 Assay 151, 397, 399 Assay validation 335, 567 Astrocyte 454 Asymptomatic neurocognitive impairment 121, 419 Atazanavir 469 Atazanavir/ritonavir 141 Atherogenic dyslipidemia 706 Atherosclerosis 631, 678, 681, 684LB, 689, 700, 78 Attrition 1092, 1095, 1140 Autophagy 193

Keyword Index

Autopsy 788 Aviremic 121 Awareness 986 Azole 794 B cell 221, 223, 285, 299, 863, 870 • Differentiation 315

• Follicle 236, 286, 353LB • Lymphoma 6 (BCL6) 327 • Responses 307, 866

Bacterial infections 1039 Bacterial translocation 266 Bacterial vaginosis 246, 268, 270 Barriers 1005, 1139 Basic reproductive number 336 Bcl-2 222 Behavioral interventions 95

CROI 2018 478